Open Market Insiders Trades - Buys only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
KFS
|
Kent A Hansen
CFO & EVP |
BUY
Open market or private purchase
|
Direct | 177 Added 0.17% |
$1,568
$8.86 p/Share
|
Jan 30
2024 |
|
MPB
|
Frank Gumina Jr
Director |
BUY
Open market or private purchase
|
Direct | 201 Added 1.05% |
$4,612
$22.95 p/Share
|
Jan 30
2024 |
|
EPSN
|
Jason Stabell
Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect | 245,200 Added 0.0% |
$1,181,864
$4.82 p/Share
|
Jan 30
2024 |
|
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Direct | 3 Added 0.12% |
$4,511
$1503.91 p/Share
|
Jan 30
2024 |
|
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Indirect | 8 Added 0.0% |
$12,033
$1504.22 p/Share
|
Jan 30
2024 |
|
COLB
|
Christopher Merrywell
Senior Executive VP |
BUY
Open market or private purchase
|
Direct | 5,000 Added 8.97% |
$105,450
$21.09 p/Share
|
Jan 30
2024 |
|
HMLA
|
Vikram P Grover
CFO |
BUY
Open market or private purchase
|
Direct | 382,353 Added 3.2% |
-
|
Jan 30
2024 |
|
MHI
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 17,517 Added 0.0% |
$148,719
$8.49 p/Share
|
Jan 30
2024 |
|
MAV
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 17,454 Added 0.0% |
$137,013
$7.85 p/Share
|
Jan 30
2024 |
|
RCG
|
Murray Stahl
President and CEO |
BUY
Open market or private purchase
|
Indirect | 55 Added 0.0% |
$89
$1.63 p/Share
|
Jan 30
2024 |
|
RCG
|
Murray Stahl
President and CEO |
BUY
Open market or private purchase
|
Direct | 1 Added 0.02% |
$1
$1.63 p/Share
|
Jan 30
2024 |
|
BIGZ
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 195,905 Added 0.0% |
$1,508,468
$7.7 p/Share
|
Jan 30
2024 |
|
BMEZ
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 59,239 Added 0.0% |
$917,612
$15.49 p/Share
|
Jan 30
2024 |
|
DMF
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 1,650 Added 0.0% |
$10,725
$6.5 p/Share
|
Jan 30
2024 |
|
BCAT
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 42,816 Added 0.0% |
$661,935
$15.46 p/Share
|
Jan 30
2024 |
|
FMNB
|
Gina A Richardson |
BUY
Open market or private purchase
|
Direct | 735 Added 20.13% |
$10,414
$14.17 p/Share
|
Jan 30
2024 |
|
COLB
|
Clint Stein
President, CEO |
BUY
Open market or private purchase
|
Direct | 9,500 Added 5.42% |
$199,120
$20.96 p/Share
|
Jan 30
2024 |
|
COLB
|
S Mae Fujita Numata
Director |
BUY
Open market or private purchase
|
Direct | 400 Added 24.62% |
$8,436
$21.09 p/Share
|
Jan 30
2024 |
|
COLB
|
S Mae Fujita Numata
Director |
BUY
Open market or private purchase
|
Direct | 2,000 Added 6.6% |
$42,180
$21.09 p/Share
|
Jan 30
2024 |
|
AUID
|
Stephen Jeffrey Garchik
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 2,500 Added 0.22% |
$22,750
$9.1 p/Share
|
Jan 30
2024 |
|
COLB
|
Mark A Finkelstein
Director |
BUY
Open market or private purchase
|
Direct | 3,592 Added 13.06% |
$74,965
$20.87 p/Share
|
Jan 30
2024 |
|
BHRB
|
Jose David Riojas
Director |
BUY
Open market or private purchase
|
Indirect | 1,126 Added 0.0% |
$67,560
$60.0 p/Share
|
Jan 30
2024 |
|
TLYS
|
Fund 1 Investments, LLC |
BUY
Open market or private purchase
|
Indirect | 20,000 Added 0.0% |
$149,200
$7.46 p/Share
|
Jan 30
2024 |
|
TTSH
|
Fund 1 Investments, LLC |
BUY
Open market or private purchase
|
Indirect | 38,600 Added 0.0% |
$251,671
$6.52 p/Share
|
Jan 30
2024 |
|
SBSI
|
Herbert C Buie
Director |
BUY
Open market or private purchase
|
Direct | 1,990 Added 0.49% |
$64,714
$32.52 p/Share
|
Jan 30
2024 |
|
GUG
|
Randall C Barnes |
BUY
Open market or private purchase
|
Direct | 385 Added 0.58% |
$5,582
$14.5 p/Share
|
Jan 30
2024 |
|
HMLA
|
Vikram P Grover
CFO |
BUY
Open market or private purchase
|
Direct | 382,353 Added 3.2% |
-
|
Jan 30
2024 |
|
GRTX
|
Yair Schneid
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 150,000 Added 2.02% |
$27,000
$0.18 p/Share
|
Jan 29
2024 |
|
ASPI
|
Robert John Andrew Ryan |
BUY
Open market or private purchase
|
Direct | 15,596 Added 2.82% |
$36,650
$2.35 p/Share
|
Jan 29
2024 |
|
BUSE
|
Karen M Jensen
Director |
BUY
Open market or private purchase
|
Direct | 2,500 Added 5.2% |
$61,000
$24.4 p/Share
|
Jan 29
2024 |
|
PAYS
|
Topline Capital Management, LLC |
BUY
Open market or private purchase
|
Indirect | 8,379 Added 0.0% |
$24,047
$2.87 p/Share
|
Jan 29
2024 |
|
PAYS
|
Topline Capital Partners, LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 8,379 Added 0.15% |
$24,047
$2.87 p/Share
|
Jan 29
2024 |
|
AKTS
|
Kenneth Boller
CFO |
BUY
Open market or private purchase
|
Direct | 60,000 Added 21.82% |
$30,000
$0.5 p/Share
|
Jan 29
2024 |
|
AKTS
|
David Aichele
EVP of Business Development |
BUY
Open market or private purchase
|
Direct | 80,000 Added 19.29% |
$40,000
$0.5 p/Share
|
Jan 29
2024 |
|
AKTS
|
Arthur Geiss |
BUY
Open market or private purchase
|
Direct | 50,000 Added 10.73% |
$25,000
$0.5 p/Share
|
Jan 29
2024 |
|
AKTS
|
Jeffrey B. Shealy
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 1,310,000 Added 37.08% |
$655,000
$0.5 p/Share
|
Jan 29
2024 |
|
RLMD
|
Chuck Ence
CA and CO |
BUY
Open market or private purchase
|
Direct | 10,800 Added 50.0% |
$39,420
$3.65 p/Share
|
Jan 29
2024 |
|
RLMD
|
Maged Shenouda
Chief Financial Officer |
BUY
Open market or private purchase
|
Direct | 10,800 Added 45.32% |
$39,420
$3.65 p/Share
|
Jan 29
2024 |
|
RLMD
|
Sergio Traversa
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 31,541 Added 15.23% |
$117,017
$3.71 p/Share
|
Jan 29
2024 |
|
ISBA
|
Gregory V Varner
Director |
BUY
Open market or private purchase
|
Direct | 931 Added 3.01% |
$19,979
$21.46 p/Share
|
Jan 29
2024 |
|
ISBA
|
Sarah R Opperman
Director |
BUY
Open market or private purchase
|
Direct | 640 Added 2.76% |
$13,734
$21.46 p/Share
|
Jan 29
2024 |
|
ISBA
|
Richard L Mc Guirk
Director |
BUY
Open market or private purchase
|
Direct | 1,397 Added 8.33% |
$29,979
$21.46 p/Share
|
Jan 29
2024 |
|
ISBA
|
Chad R Payton
Director |
BUY
Open market or private purchase
|
Direct | 512 Added 6.95% |
$10,987
$21.46 p/Share
|
Jan 29
2024 |
|
ISBA
|
Jae A Evans
Director |
BUY
Open market or private purchase
|
Direct | 465 Added 1.22% |
$9,978
$21.46 p/Share
|
Jan 29
2024 |
|
ISBA
|
Jill Bourland
Director |
BUY
Open market or private purchase
|
Direct | 559 Added 10.65% |
$11,996
$21.46 p/Share
|
Jan 29
2024 |
|
RCUS
|
Gilead Sciences Inc
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 15,238,095 Added 33.64% |
$319,999,995
$21.0 p/Share
|
Jan 29
2024 |
|
CGON
|
Hong Fang Song |
BUY
Open market or private purchase
|
Direct | 263,157 Added 30.0% |
$4,999,983
$19.0 p/Share
|
Jan 29
2024 |
|
CGON
|
Corleen M. Roche
CFO |
BUY
Open market or private purchase
|
Direct | 2,000 Added 50.0% |
$38,000
$19.0 p/Share
|
Jan 29
2024 |
|
CGON
|
Vijay Kasturi
Chief Medical Officer |
BUY
Open market or private purchase
|
Direct | 1,315 Added 50.0% |
$24,985
$19.0 p/Share
|
Jan 29
2024 |
|
TALS
|
Mark Mcdade
Director |
BUY
Open market or private purchase
|
Indirect | 100,000 Added 0.0% |
$3,250,000
$32.5 p/Share
|
Jan 29
2024 |